PMCB
PharmaCyte Biotech, Inc. · Healthcare
Insiders bought $129K net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Jan 7, 2026
Insider Buying
$129K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Jan 7, 2026
Silverman Joshua
PharmaCyte Biotech, Inc. (PMCB) has 7 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jan 7, 2026.
Inside the rolling window, 2 insiders at PharmaCyte Biotech, Inc. reported 6 open-market purchases totaling $129K and no open-market sales. The most active filer is CEO and President Silverman Joshua with 3 filings. Insiders have net bought $129K over the trailing 6 months. The most recent open-market filing is a purchase of 30,000 shares by CEO and President Silverman Joshua, dated Jan 5, 2026, worth $23K.
- Industry:Biotechnology
- CEO:Joshua N. Silverman
- Employees:2
- HQ:Las Vegas, NV, US
- IPO:2013-01-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Silverman JoshuaFirst filing | CEO and President | Purchase | 30,000 | $23K | Jan 7 | — | SEC ↗ |
Silverman JoshuaFirst filing | CEO and President | Purchase | 30,000 | $24K | Jan 7 | — | SEC ↗ |
Silverman JoshuaFirst filing | CEO and President | Purchase | 40,000 | $33K | Jan 7 | — | SEC ↗ |
| Director | Purchase | 20,000 | $16K | Jan 7 | — | SEC ↗ | |
| Director | Purchase | 20,000 | $16K | Jan 7 | — | SEC ↗ | |
| Director | Purchase | 20,000 | $17K | Jan 7 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does PMCB have?
PharmaCyte Biotech, Inc. (PMCB) has 7 SEC Form 4 filings (16 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jan 7, 2026.
When was the most recent SEC Form 4 filing for PMCB?
The most recent Form 4 filing for PMCB on Tracefour is dated Jan 7, 2026.
Who is the most active insider at PMCB?
The most active SEC Form 4 filer at PMCB in the rolling window is CEO and President Silverman Joshua, with 3 filings.
What is the net insider flow at PMCB over the last 6 months?
Over the trailing 180 days, insiders at PMCB have net bought $129K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PMCB in the current window?
Inside the rolling window, insiders at PMCB bought $129K and sold $0 based on SEC Form 4 filings.
Can I get alerts for PMCB insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PharmaCyte Biotech, Inc. (PMCB). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
PharmaCyte Biotech, Inc. is in the Healthcare sector.